BRCA1 and ovarian cancer: While reconciling multiple sources of data, including population data, case-control studies, computational predictions, and well-established in vitro functional assays like the one used in the current study, the interpretation of the effects of BRCA1 variants on breast and ovarian cancer predisposition can be difficult.